Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease (Q36655337)

15 August 2017

1 reference

title

Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease (English)

1 reference

15 August 2017

Jason C Kovacic

1

1 reference

15 August 2017

David W M Muller

series ordinal

2

1 reference

15 August 2017

Robert M Graham

series ordinal

3

1 reference

15 August 2017

publication date

15 November 2006

1 reference

Journal of Molecular and Cellular Cardiology

15 August 2017

published in

1 reference

15 August 2017

volume

42

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

19-33

1 reference

Update on the use of stem cells for cardiac disease

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

G-CSF: a key regulator of neutrophil production, but that's not all!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Production of granulocyte colony-stimulating factor in the nonspecific acute phase response enhances host resistance to bacterial infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Hematopoietic stem cells are uniquely selective in their migratory response to chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Characterization of hematopoietic progenitor mobilization in protease-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Low CXCR4 membrane expression on CD34(+) cells characterizes cells mobilized to blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Regulation of the chemokine receptor CXCR4 by hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

SDF-1 is both necessary and sufficient to promote proliferative retinopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Oxygen saturation in the bone marrow of healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Transdifferentiation of Blood-Derived Human Adult Endothelial Progenitor Cells Into Functionally Active Cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Endothelial progenitor cells: neovascularization or more?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Bone marrow cells regenerate infarcted myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Endogenous bone-marrow-derived stem cells contribute only a small proportion of regenerated myocardium in the acute infarction model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement [corrected].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Profound thrombocytopenia related to G-CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

In vitro and in vivo activation of endothelial cells by colony-stimulating factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

An in vitro model for the study of human bone marrow angiogenesis: role of hematopoietic cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

AIF-1 expression modulates proliferation of human vascular smooth muscle cells by autocrine expression of G-CSF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte-colony stimulating factor directly enhances proliferation of human troponin I-positive cells derived from idiopathic dilated cardiomyopathy through specific receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Therapeutic induction of arteriogenesis in hypoperfused rat brain via granulocyte-macrophage colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Mobilized Endothelial Progenitor Cells by Granulocyte-Macrophage Colony-Stimulating Factor Accelerate Reendothelialization and Reduce Vascular Inflammation After Intravascular Radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte macrophage-colony stimulating factor increases the expression of histamine and histamine receptors in monocytes/macrophages in relation to arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Mobilized bone marrow cells repair the infarcted heart, improving function and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Hematopoietic stem cells do not repair the infarcted mouse heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte colony-stimulating factor and stem cell factor improve contractile reserve of the infarcted left ventricle independent of restoring muscle mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte colony-stimulating factor mediates cardioprotection against ischemia/reperfusion injury via phosphatidylinositol-3-kinase/Akt pathway in canine hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Adult cardiac stem cells are multipotent and support myocardial regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

G-CSF treatment increases side population cell infiltration after myocardial infarction in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Intracoronary injection of granulocyte colony-stimulating factor ameliorates the progression of left ventricular remodeling after myocardial ischemia/reperfusion in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Review: Inducer of cytokines in vivo: Overview of field and romurtide experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Bone marrow is a source of regenerated cardiomyocytes in doxorubicin-induced cardiomyopathy and granulocyte colony-stimulating factor enhances migration of bone marrow cells and attenuates cardiotoxicity of doxorubicin under electron microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte colony-stimulating factor reduces cardiomyocyte apoptosis and improves cardiac function in adriamycin-induced cardiomyopathy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Treatment with granulocyte colony-stimulating factor ameliorates chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte-macrophage colony-stimulating factor-induced arteriogenesis reduces energy failure in hemodynamic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Coronary collateral flow and peripheral blood monocyte concentration in patients treated with granulocyte-macrophage colony stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: double-edged swords

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Effect of granulocyte colony-stimulating factor treatment at a low dose but for a long duration in patients with coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Myocardial gene expression of angiogenic factors in human chronic ischemic myocardium: influence of acute ischemia/cardioplegia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Safety and effectiveness of granulocyte-colony stimulating factor in mobilizing stem cells and improving cytokine profile in advanced chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Stem-cell therapy for myocardial diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

In-stent neo-intimal hyperplasia after stem cell mobilization by granulocyte-colony stimulating factor Preliminary intracoronary ultrasound results from a double-blind randomized placebo-controlled study of patients treated with percutaneous coronar

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Granulocyte colony-stimulating factor-induced blood stem cell mobilisation in patients with chronic heart failure--Feasibility, safety and effects on exercise tolerance and cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimul

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Effects of Granulocyte Colony Stimulating Factor on Functional Activities of Endothelial Progenitor Cells in Patients With Chronic Ischemic Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

G-CSF induces E-selectin ligand expression on human myeloid cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.10.001

10.1016/J.YJMCC.2006.10.001

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference